Background The number of older adults has been constantly growing around the globe.
Consequently, multimorbidity and related polypharmacy have become an increasing …

Background Multimorbidity and the associated use of multiple medicines (polypharmacy), is
common in the older population. Despite this, there is no consensus definition for …

Introduction: Polypharmacy, the use of multiple medications by one individual, is
increasingly common among older adults. Caring for the growing number of older people …

A high rate of polypharmacy is, in part, a consequence of the increasing proportion of
multimorbidity in the ageing population worldwide. Our understanding of the potential harm …

Introduction: Polypharmacy, defined as the use of multiple drugs or more than are medically
necessary, is a growing concern for older adults. MEDLINE and EMBASE databases were …

Introduction Ageing—along with its associated physiological and pathological changes—
places individuals at a higher risk of multimorbidity and treatment-related complications …

Objective Polypharmacy is widespread among older people, but the adverse outcomes
associated with it are unclear. We aim to synthesize current evidence on the adverse health …

Introduction Polypharmacy is commonly associated with adverse health outcomes. There
are currently no meta-analyses of the prevalence of polypharmacy or factors associated with …

There are numerous definitions of polypharmacy to describe the use of many medications
among older adults, but there is a need to clarify if they are purposive and meaningful. By …

Background Guideline-oriented treatments can lead to polypharmacy, ie, the simultaneous
long-term use of multiple drugs. Polypharmacy mainly affects elderly patients. The goal of …